21.39
+0.4(+1.91%)
Currency In USD
| Previous Close | 20.99 |
| Open | 21.4 |
| Day High | 22.19 |
| Day Low | 20.63 |
| 52-Week High | 26.58 |
| 52-Week Low | 19.05 |
| Volume | 1.92M |
| Average Volume | 1.48M |
| Market Cap | 2.63B |
| PE | 12.51 |
| EPS | 1.71 |
| Moving Average 50 Days | 20.5 |
| Moving Average 200 Days | 22.04 |
| Change | 0.4 |
If you invested $1000 in Catalyst Pharmaceuticals, Inc. (CPRX) 10 years ago, it would be worth $6,684.38 as of November 08, 2025 at a share price of $21.39. Whereas If you bought $1000 worth of Catalyst Pharmaceuticals, Inc. (CPRX) shares 5 years ago, it would be worth $6,462.24 as of November 08, 2025 at a share price of $21.39.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work
GlobeNewswire Inc.
Nov 04, 2025 9:03 PM GMT
CORAL GABLES, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for
Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference
GlobeNewswire Inc.
Nov 03, 2025 1:03 PM GMT
CORAL GABLES, Fla., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for
Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025
GlobeNewswire Inc.
Oct 22, 2025 12:03 PM GMT
The Company will Host a Conference Call and Webcast on Thursday, November 6, 2025, at 8:30 AM ETCORAL GABLES, Fla., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopha